Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer – Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

By Hedlund Per Olov   Ala-Opas Martti   Brekkan Einar   Damber Jan Erik   Damber Lena   Hagerman Inger   Haukaas Svein   Henriksson Peter   Iversen Peter   Pousette Åke   Rasmussen Finn   Salo Jaakko   Vaage Sigmund   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 6, 2002-12 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite

Subcapsular versus total orchiectomy in the treatment of advanced prostate cancer: A randomized trial

By Roosen Jens Ulrik   Klarskov Ole Peter   Mogensen Peter  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 6, 2005-12 ,pp. : 464-467

Informa Healthcare

Access to resources Recommend Favorite

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

By Hedlund Per Olov   Johansson Robert   Damber Jan Erik   Hagerman Inger   Henriksson Peter   Iversen Peter   Klarskov Peter   Mogensen Peter   Rasmussen Finn   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 5, 2011-11 ,pp. : 346-353

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Effects of Total Enteral versus Total Parenteral Nutrition on Ischemia/Reperfusion-Induced Heart Injury in Rats

By  

European Surgical Research, Vol. 40, Iss. 4, 2008-03 ,pp. : 361-367

Karger

Access to resources Recommend Favorite

Pilot attempt of advanced prostate cancer treatment T3NxMx−1 by intermittent more complete androgen blockade

By Dutkiewicz Slawomir  

International Urology and Nephrology, Vol. 36, Iss. 3, 2004-09 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite